Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Corcept Therapeutics Incorporated (CORT) had Operating Cash Flow per Share of $0.87 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$207.64M |
|
$19.36M |
|
$4.60M |
|
$203.04M |
|
$197.42M |
|
$10.22M |
|
$5.02M |
|
$15.24M |
|
$15.24M |
|
$19.67M |
|
$19.67M |
|
$19.67M |
|
$19.67M |
|
$10.22M |
|
$10.70M |
|
103.55M |
|
119.44M |
|
$0.19 |
|
$0.16 |
|
| Balance Sheet Financials | |
$541.13M |
|
$2.09M |
|
$282.48M |
|
$823.61M |
|
$172.26M |
|
$5.31M |
|
$19.44M |
|
$191.71M |
|
$631.90M |
|
$631.90M |
|
$631.90M |
|
105.12M |
|
| Cash Flow Statement Financials | |
$103.55M |
|
$81.60M |
|
$-189.15M |
|
$127.67M |
|
$125.14M |
|
$-2.53M |
|
$63.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.14 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
97.79% |
|
4.92% |
|
4.92% |
|
-- |
|
7.34% |
|
9.32% |
|
$103.39M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.37 |
|
2.98 |
|
30.18 |
|
3.11% |
|
3.11% |
|
2.39% |
|
3.09% |
|
$6.01 |
|
$0.87 |
|
|
Operating Cash Flow per Share |
$0.87 |